Mironneau J, Sayet I, Rakotoarisoa L, Dacquet C, Mironneau C
Laboratoire de Physiologie Cellulaire et Pharmacologie Moléculaire, INSERM Jeune Formation 88-13, Université de Bordeaux, France.
Br J Pharmacol. 1990 Sep;101(1):6-7. doi: 10.1111/j.1476-5381.1990.tb12077.x.
Spironolactone partially inhibited the specific binding of (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil to vascular smooth muscle membranes. It is suggested that spironolactone interacts at a binding site of the calcium channel complex and allosterically modulates ligand binding at receptor sites in the channel.
螺内酯部分抑制(+)-[³H]-伊拉地平及(-)-[³H]-去甲氧基维拉帕米与血管平滑肌膜的特异性结合。提示螺内酯在钙通道复合物的结合位点相互作用,并对通道中受体位点的配体结合产生变构调节作用。